Identifying neuroimaging biomarkers of bipolar depression (MODEM)

Overview

PARTICIPANTS WANTED FOR BRAIN SCAN STUDY
Who are we looking for?
Adults between 18-55 years of age
Right-handed
Experiencing depressive symptoms or diagnosed with depression (unipolar / bipolar)
Unmedicated
Get paid £150 plus a chance to win a further £20

HELP US IDENTIFY NEUROIMAGING BIOMARKERS OF BIPOLAR DEPRESSION

Are you interested in taking part in this study? 

Find out more by filling in this form

Planned end date

30 Apr 2024 00:00

Conditions

Bipolar Disorder,Depression

Inclusion Criteria

1. Right-handed participants between the ages of 18 and 55 years.
2. Evidence of a personally signed and dated informed consent document indicating that the subject has been
informed of all pertinent aspects of the trial.
3. Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.
4. Ability to understand written and verbal instructions in English.
Additional inclusion criteria for participants with bipolar disorder and major depressive disorder
5. Participants must fulfil DSM5 criteria for bipolar disorder or major depressive disorder and be experiencing a
depressed episode (score >5 on the Quick Inventory for Depressive Symptoms-Clinician Report (QIDS-CR).

Exclusion Criteria

1. Evidence or history of clinically significant haematological, renal, endocrine, pulmonary, gastrointestinal,
cardiovascular, hepatic, neurologic, or allergic disease (including drug allergies, but excluding untreated,
asymptomatic, seasonal allergies at time of dosing), and any primary psychiatric diagnosis other than bipolar disorder
or major depressive disorder.
2. Recent influenza vaccination.
3. Treatment with an experimental medicine drug within one month preceding the first study day, over the course of the
study.
4. A positive urine drug screen on or after the screening visit during their active involvement in the study for opiates,
methadone, cocaine, amphetamines (including MDMA), barbiturates, benzodiazepines and cannabinoids.
5. Participants who, in the opinion of the investigator, have any medical or psychological condition or social
circumstances which would impair their ability to participate reliably in the study, or who may increase the risk to
themselves or others by participating.
6. Diagnosis of alcohol or drug dependence in the year prior to recruitment or diagnosis of harmful use of alcohol or
drugs within the previous 6 months (excluding nicotine).
7. Female participants that are currently pregnant or are breast feeding.
8. A history of moderate to severe head injury or neurological conditions that may impair cognitive performance.
9. Ineligibility to undergo MRI imaging, for example the presence of a cardiac pacemaker or other electronic device or
ferromagnetic metal foreign bodies as assessed by a standard pre-MRI questionnaire.
10. Participant weight in excess of 126kg or physical dimensions such that the participant may not fit in the MRI
scanner.
11. A history of claustrophobia or participant feels unable to lie in an MRI scanner for a period of around one hour.
12. Any other reason that in the opinion of the investigator may impact the safety of participants or the integrity of the
data.
Additional exclusion criteria for participants with bipolar disorder or major depressive disorder
13. Currently taking any psychotropic medication.
14. No evidence of anhedonia (as measured by a score of 0 on the anhedonia question of the HAM-D questionnaire).
15. Current manic state (as measured by a score of > 8 on the YMRS).
Additional exclusion criteria for healthy participants
16. A personal history of any significant psychiatric disorder including a history of suicide attempts or significant
suicidal ideation or a family history in first degree relatives of severe mental illness (such as psychosis, bipolar
disorder or schizophrenia).

Global Banner